Dow Completes Acquisition of Biotechnology Services Division from The Collaborative Group
This transaction includes the integration of the Biotechnology Services Division's employees and assets into Dow's Industrial Biotechnology Business. The acquisition is focused on growing and expanding Dow's capabilities and building Dow's presence in contract biopharmaceutical development and manufacturing for a wide range of products. This transaction will allow both Dow and The Collaborative Group to strengthen and grow their respective customer bases, nationally and internationally.
The Dow Chemical Company is a leading science and technology company that provides innovative chemical, plastic and agricultural products and services to many essential consumer markets. With annual sales of $19 billion, Dow serves customers in 162 countries and a wide range of markets that are vital to human progress, including food, transportation, health and medicine, personal and home care, and building and construction, among others. Committed to the principles of sustainable development, Dow and its 41,000 employees seek to balance economic, environmental and social responsibilities. For more news and information about Dow, please visit www.dow.com.
Most read news
Topics
Organizations
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.